Guilherme Nader Marta

A phase 2 study of first‐line nivolumab in patients with locally advanced or metastatic cutaneous squamous‐cell carcinoma

Rodrigo Ramella Munhoz, Guilherme Nader Marta, Veridiana Pires de Camargo et al. · Cancer · 2022 · 51 citations

Pharmacy, Oncology, Pharmacotherapy +17

Trends in Melanoma Mortality in Brazil: A Registry-Based Study

Guilherme Nader Marta, Rodrigo Ramella Munhoz, Mônica La Porte Teixeira et al. · JCO Global Oncology · 2020 · 24 citations · Full text

Medicine, Dermatology, Oncology +17

First-in-human study of SBRT and adenosine pathway blockade to potentiate the benefit of immunochemotherapy in early-stage luminal B breast cancer: results of the safety run-in phase of the Neo-CheckRay trial

Alex De Caluwé, Emanuela Romano, P. Poortmans et al. · Journal for ImmunoTherapy of Cancer · 2023 · 23 citations · Full text

Medicine, Oncology, Pharmacology +17

Outcomes and Prognostic Factors in a Large Cohort of Hospitalized Cancer Patients With COVID-19

Guilherme Nader Marta, Renata Colombo Bonadio, Odeli Nicole Encinas Sejas et al. · JCO Global Oncology · 2021 · 21 citations · Full text

Medicine, Infectious Diseases, Oncology +12

Treatment priorities in oncology: do we want to live longer or better?

Guilherme Nader Marta, Luís G Del Nero, Gustavo Nader Marta et al. · Clinics · 2014 · 19 citations · Full text

Medicine, Oncology, Cancer Control +10